The risk of hepatic adverse events of systemic medications for psoriasis: a prospective cohort study using the BIOBADADERM registry
Background Limited information is available regarding the risk of incident liver disease in patients with psoriasis receiving systemic therapies. Objectives To describe the liver safety findings of conventional and modern systemic therapies for moderate-to-severe psoriasis, and to compare the relati...
Main Authors: | Mónica Munera-Campos, Jaime Vilar-Alejo, Raquel Rivera, Jose-Manuel Carrascosa, Esteban Daudén, Enrique Herrera-Acosta, Antonio Sahuquillo-Torralba, Francisco J. Gómez-García, Ofelia Baniandrés-Rodríguez, Pablo de la Cueva, Jose-Luis López-Estebaranz, Isabel Belinchón, Marta Ferran, Jose Riera-Monroig, Lourdes Rodriguez, Gregorio Carretero, Carmen García-Donoso, Ferran Ballescá, Mar Llamas-Velasco, Enrique Herrera-Ceballos, Conrad Pujol-Marco, Lula María Nieto-Benito, Diana P. Ruiz-Genao, Mercè Alsina, Miguel A. Descalzo, Ignacio García-Doval, the BIOBADADERM Study Group |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-05-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2021.1922572 |
Similar Items
-
Safety and effectiveness of conventional systemic therapy and biological drugs in patients with moderate to severe psoriasis and HIV infection: a retrospective multicenter study
by: Andrea Montes-Torres, et al.
Published: (2019-07-01) -
PASI 100 response rates in moderate to severe psoriasis: a systematic literature review and analysis of clinical practice guidelines
by: Isabel Belinchón Romero, et al.
Published: (2022-04-01) -
First experiences in real clinical practice treating a patient with generalised pustular psoriasis with Spesolimab
by: Aurora Fernández‐Galván, et al.
Published: (2023-06-01) -
Effectiveness and safety of ustekinumab 90 mg in patients weighing 100 kg or less: a retrospective, observational, multicenter study
by: Elena del Alcázar, et al.
Published: (2020-04-01) -
Therapeutic goals and treatment response evaluation in moderate to severe psoriasis: an experts opinion document
by: Isabel Belinchón Romero, et al.
Published: (2021-01-01)